Modified Tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications

Virology

Volumn 348, Issue 2, 2006, Pages 475-488

  Smith, Mark L ^a   Lindbo, John A ^a   Dillard Telm, Stephan ^a   Brosio, Paul M ^a   Lasnik, Amanda B ^a   McCormick, Alison A ^a   Nguyen, Long V ^a   Palmer, Kenneth E ^a  

^a Large Scale Biology Corporation   (United States)

Author keywords

Antibodies; Biotin; Green fluorescent protein; Papillomavirus; Plant vaccine; Solubility; Streptavidin fusion; Tobacco mosaic virus

Indexed keywords

ANTIGEN; CAPSID PROTEIN; COAT PROTEIN; GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN G ANTIBODY; PROTEIN L2; STREPTAVIDIN; TETRAMER; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIBODY TITER; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; FEMALE; GUINEA PIG; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; TOBACCO MOSAIC VIRUS; VIRION; VIRUS CAPSID; VIRUS PARTICLE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; BASE SEQUENCE; DNA, VIRAL; DOGS; FEMALE; GREEN FLUORESCENT PROTEINS; GUINEA PIGS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; PAPILLOMAVIRIDAE; PEPTIDE LIBRARY; RECOMBINANT FUSION PROTEINS; STREPTAVIDIN; TOBACCO; TOBACCO MOSAIC VIRUS; VACCINES, SYNTHETIC; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

CANINE ORAL PAPILLOMAVIRUS; CAVIA; CAVIA PORCELLUS; MIRIDAE; PAPILLOMAVIRIDAE; TOBACCO MOSAIC VIRUS;

EID: 33646256795     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.12.039     Document Type: Article

References (45)

1. Bachmann M.F., Rohrer U.H., Kundig T.M., Burki K., Hengartner H., and Zinkernagel R.M. The influence of antigen organization on B-cell responsiveness. Science 262 5138 (1993) 1448-1451
2. Bachmann M.F., Zinkernagel R.M., and Oxenius A. Cutting edge commentary: immune responses in the absence of costimulation: viruses know the trick. J. Immunol. 161 11 (1998) 5791-5794
3. Bayer E.A., Benhur H., and Wilchek M. Isolation and properties of streptavidin. Methods Enzymol. 184 (1990) 80-89
4. Bendahmane M., Koo M., Karrer E., and Beachy R.N. Display of epitopes on the surface of tobacco mosaic virus: impact of charge and isoelectric point of the epitope on virus-host interactions. J. Mol. Biol. 290 1 (1999) 9-20
5. Birkett A., Lyons K., Schmidt A., Boyd D., Oliveira G.A., Siddique A., Nussenzweig R., Calvo-Calle J.M., and Nardin E. A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts. Infect. Immun. 70 12 (2002) 6860-6870
6. Bojang K.A., Milligan P.J.M., Pinder M., Vigneron L., Alloueche A., Kester K.E., Ballou W.R., Conway D.J., Reece W.H.H., Gothard P., Yamuah L., Delchambre M., Voss G., Greenwood B.M., Hill A., McAdam K., Tornieporth N., Cohen J.D., and Doherty T. Efficacy of RTS,S/ASO2 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 358 9297 (2001) 1927-1934
7. Chackerian B., Lowy D.R., and Schiller J.T. Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. J. Clin. Invest. 108 3 (2001) 415-423
8. Chatterji A., Ochoa W., Shamieh L., Salakian S.P., Wong S.M., Clinton G., Ghosh P., Lin T.W., and Johnson J.E. Chemical conjugation of heterologous proteins on the surface of cowpea mosaic virus. Bioconjugate Chem. 15 4 (2004) 807-813
9. Compton S.J., and Jones C.G. Mechanism of dye response and interference in the Bradford protein assay. Anal. Biochem. 151 2 (1985) 369-374
10. de Moreno M.R., Smith J.F., and Smith R.V. Mechanism studies of Coomassie Blue and silver staining of proteins. J. Pharm. Sci. 75 9 (1986) 907-911
11. Demir M., and Stowell M.H.B. A chemoselective biomolecular template for assembling diverse nanotubular materials. Nanotechnology 13 4 (2002) 541-544
12. Filner B., and Marcus A. TMV coat protein synthesis in vivo: analysis of the N-terminal acetylation. Virology 61 2 (1974) 537-546
13. Gallizia A., de Lalla C., Nardone E., Santambrogio P., Brandazza A., Sidoli A., and Arosio P. Production of a soluble and functional recombinant streptavidin in Escherichia coli. Protein Expression Purif. 14 2 (1998) 192-196
14. Gooding G.V., and Hebert T.T. A simple technique for purification of tobacco mosaic virus in large quantities. Phytopathology 57 (1967) 1285
15. Gregory D.W., and Pirie B.J.S. Wetting agents for biological electron microscopy: I. General considerations and negative staining. J. Microscopy 99 3 (1973) 261-265
16. Harper D.M., Franco E.L., Wheeler C., Ferris D.G., Jenkins D., Schuind A., Zahaf T., Innis B., Naud P., De Carvalho N.S., Roteli-Martins C.M., Teixeira J., Blatter M.M., Korn A.P., Quint W., and Dubin G. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364 9447 (2004) 1757-1765
17. Hilleman M.R. Plasma-derived hepatitis B vaccine: a breakthrough in preventive medicine. In: Ellis R.W. (Ed). Hepatitis B Vaccines in Clinical Practice (1992), Marcel Dekker, New York 17-39
18. Hofmann K., Wood S.W., Brinton C.C., Montibeller J.A., and Finn F.M. Iminobiotin affinity columns and their application to retrieval of streptavidin. Proc. Natl. Acad. Sci. U.S.A. 77 8 (1980) 4666-4668
19. Jegerlehner A., Tissot A., Lechner F., Sebbel P., Erdmann I., Kundig T., Bachi T., Storni T., Jennings G., Pumpens P., Renner W.A., and Bachmann M.F. A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses. Vaccine 20 25-26 (2002) 3104-3112
20. Karas M., and Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal. Chem. 60 20 (1988) 2299-2301
21. Karpenko L.I., Ivanisenko V.A., Pikal I.A., Chikaev N.A., Eroshkin A.M., Veremeiko T.A., and Ilyichev A.A. Insertion of foreign epitopes in HBcAg: how to make the chimeric particle assemble. Amino Acids 18 4 (2000) 329-337
22. Kimalov B., Gal-On A., Stav R., Belausov E., and Arazi T. Maintenance of coat protein N-terminal net charge and not primary sequence is essential for zucchini yellow mosaic virus systemic infectivity. J. Gen. Virol. 85 11 (2004) 3421-3430
23. Kipriyanov S.M., Dubel S., Breitling F., Kontermann R.E., Heymann S., and Little M. Bacterial expression and refolding of single-chain Fv fragments with C-terminal cysteines. Cell. Biophys. 26 3 (1995) 187-204
24. Kratz P.A., Bottcher B., and Nassal M. Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc. Natl. Acad. Sci. U.S.A. 96 5 (1999) 1915-1920
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
26. Lizee G., Basha G., Tiong J., Julien J.P., Tian M.M., Biron K.E., and Jefferies W.A. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat. Immunol. 4 11 (2003) 1065-1073
27. Loor F. Comparative immunogenicities of tobacco mosaic virus, protein subunits, and reaggregated protein subunits. Virology 33 (1967) 215-220
28. Murray C., Sutherland P.W., Phung M.M., Lester M.T., Marshall R.K., and Christeller J.T. Expression of biotin-binding proteins, avidin and streptavidin, in plant tissues using plant vacuolar targeting sequences. Transgenic Res. 11 2 (2002) 199-214
29. Nardin E.H., Oliveira G.A., Calvo-Calle J.M., Castro Z.R., Nussenzweig R.S., Schmeckpeper B., Hall B.F., Diggs C., Bodison S., and Edelman R. Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes. J. Infect. Dis. 182 5 (2000) 1486-1496
30. Nassal M., Skamel C., Kratz P.A., Wallich R., Stehle T., and Simon M.M. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula. Eur. J. Immunol. 35 2 (2005) 655-665
31. Negrouk V., Eisner G., Midha S., Lee H., Bascomb N., and Gleba Y. Affinity purification of streptavidin using tobacco mosaic virus particles as purification tags. Anal. Biochem. 333 2 (2004) 230-235
32. Pastrana D., Gambhira R., Buck C., Pang Y., Thompson C., Culp T., Christensen N., Lowy D., Schiller J., and Roden R. Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2. Virology 337 2 (2005) 365-372
33. Pogue G.P., Lindbo J.A., Garger S.J., and Fitzmaurice W.P. Making an ally from an enemy: plant virology and the new agriculture. Annu. Rev. Phytopathol. 40 (2002) 45-74
34. Porta C., Spall V.E., Findlay K.C., Gergerich R.C., Farrance C.E., and Lomonossoff G.P. Cowpea mosaic virus-based chimaeras-Effects of inserted peptides on the phenotype, host range, and transmissibility of the modified viruses. Virology 310 1 (2003) 50-63
35. Roden R., Yutzy W., Fallon R., Inglis S., DR L., and Schiller J. Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes. Virology 270 2 (2000) 254-257
36. Sano T., and Cantor C.R. A streptavidin-protein-A chimera that allows one-step production of a variety of specific antibody conjugates. Bio/Technology 9 12 (1991) 1378-1381
37. Sano T., and Cantor C.R. Streptavidin-containing chimeric proteins: design and production. Methods Enzymol. 326 (2000) 305-311
38. Santa Cruz S., Chapman S., Roberts A.G., Roberts I.M., Prior D.A.M., and Oparka K.J. Assembly and movement of a plant virus carrying a green fluorescent protein overcoat. Proc. Natl. Acad. Sci. U.S.A. 93 13 (1996) 6286-6290
39. Schlick T.L., Ding Z.B., Kovacs E.W., and Francis M.B. Dual-surface modification of the tobacco mosaic virus. J. Am. Chem. Soc. 127 11 (2005) 3718-3723
40. Shivprasad S., Pogue G.P., Lewandowski D.J., Hidalgo J., Donson J., Grill L.K., and Dawson W.O. Heterologous sequences greatly affect foreign gene expression in tobacco mosaic virus-based vectors. Virology 255 2 (1999) 312-323
41. Smolenska L., Roberts I.M., Learmonth D., Porter A.J., Harris W.J., Wilson T.M.A., and Santa Cruz S. Production of a functional single chain antibody attached to the surface of a plant virus. FEBS Lett. 441 3 (1998) 379-382
42. Stoute J.A., Kester K.E., Krzych U., Wellde B.T., Hall T., White K., Glenn G., Ockenhouse C.F., Garcon N., Schwenk R., Lanar D.E., Sun P., Momin P., Wirtz R.A., Golenda C., Saloui M., Wortmann G., Holland C., Dowler M., Cohen J., and Ballou W.R. Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine. J. Infect. Dis. 178 4 (1998) 1139-1144
43. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76 9 (1979) 4350-4354
44. Villa L.L., Costa R.L.R., Petta C.A., Andrade R.P., Ault K.A., Giuliano A.R., Wheeler C.M., Koutsky L.A., Malm C., Lehtinen M., Skjeldestad F.E., Olsson S.E., Steinwall M., Brown D.R., Kurman R., Ronnett B.M., Stoler M.H., Ferenczy A., Harper D.M., Tamms G.M., Yu J., Lupinacci L., Railkar R., Taddeo F.J., Jansen K.U., Esser M.T., Sings H.L., and Saah A.J. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 6 5 (2005) 271-278
45. Wu L.G., Jiang L.B., Zhou Z.A., Fan J.H., Zhang Q.Q., Zhu H.H., Han Q., and Xu Z.K. Expression of foot-and-mouth disease virus epitopes in tobacco by a tobacco mosaic virus-based vector. Vaccine 21 27-30 (2003) 4390-4398